Retrospective comparison of fludarabine in combination with intermediate-dose cytarabine versus high-dose cytarabine as consolidation therapies for acute myeloid leukemia.

about

Retrospective comparison of fludarabine in combination with intermediate-dose cytarabine versus high-dose cytarabine as consolidation therapies for acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q36152664

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Retrospective comparison of fl ...... es for acute myeloid leukemia.

@ast

Retrospective comparison of fl ...... es for acute myeloid leukemia.

@en

type

Item

label

Retrospective comparison of fl ...... es for acute myeloid leukemia.

@ast

Retrospective comparison of fl ...... es for acute myeloid leukemia.

@en

prefLabel

Retrospective comparison of fl ...... es for acute myeloid leukemia.

@ast

Retrospective comparison of fl ...... es for acute myeloid leukemia.

@en

P1476

Retrospective comparison of fl ...... es for acute myeloid leukemia.

@en

P2093

Aibin Liang

http://www.w3.org/2001/XMLSchema#string

Chunying Chen

http://www.w3.org/2001/XMLSchema#string

Hao Wu

http://www.w3.org/2001/XMLSchema#string

Huina Lu

http://www.w3.org/2001/XMLSchema#string

Jianfei Fu

http://www.w3.org/2001/XMLSchema#string

Shanhua Zou

http://www.w3.org/2001/XMLSchema#string

Weiguang Wang

http://www.w3.org/2001/XMLSchema#string

Wenjun Zhang

http://www.w3.org/2001/XMLSchema#string

Yi Ding

http://www.w3.org/2001/XMLSchema#string

Yuhua Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical study of Mito-FLAG regimen in treatment of relapsed acute myeloid leukemia

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study

A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blas

A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.

P304

e134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000000134

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25501050

http://www.w3.org/2001/XMLSchema#string

P932

4602804

http://www.w3.org/2001/XMLSchema#string